A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival
Crossref DOI link: https://doi.org/10.1007/s10120-015-0490-3
Published Online: 2015-04-08
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Young-Woo
Kim, Mi-Jung
Ryu, Keun Won
Lim, Hyeong-Seok
Lee, Jun Ho
Kong, Sun-Young
Lee, Jong Seok
Choi, Il Ju
Kim, Chan Gyoo
Lee, Jong Yeul
Cho, Soo-Jeong
Kook, Myeong-Cherl
Park, Young-Iee
Kim, Seok-Ki
Park, Sook Ryun
Text and Data Mining valid from 2015-04-08